Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies.

Saved in:
Bibliographic Details
Title: Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies.
Authors: Stahl A; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. aaron.m.stahl@gmx.de.; Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, University of Tübingen, Tübingen, Germany. aaron.m.stahl@gmx.de., Büringer K; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany., Missios P; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; Center for Personalized Medicine, Eberhard-Karls University, Tübingen, Germany., Hoffmann T; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany., Mattern S; Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Singer S; Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Schäfer-Ruoff F; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Malek NP; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; Center for Personalized Medicine, Eberhard-Karls University, Tübingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tübingen, Germany., Schenke-Layland K; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, University of Tübingen, Tübingen, Germany., Bitzer M; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany. m.bitzer@med.uni-tuebingen.de.; Center for Personalized Medicine, Eberhard-Karls University, Tübingen, Germany. m.bitzer@med.uni-tuebingen.de.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tübingen, Germany. m.bitzer@med.uni-tuebingen.de., Templin MF; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. markus.templin@nmi.de.
Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Feb 25; Vol. 10 (1). Date of Electronic Publication: 2026 Feb 25.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41741733
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stahl+A%22">Stahl A</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. aaron.m.stahl@gmx.de.; Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, University of Tübingen, Tübingen, Germany. aaron.m.stahl@gmx.de.<br /><searchLink fieldCode="AU" term="%22Büringer+K%22">Büringer K</searchLink>; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Missios+P%22">Missios P</searchLink>; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; Center for Personalized Medicine, Eberhard-Karls University, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+T%22">Hoffmann T</searchLink>; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Mattern+S%22">Mattern S</searchLink>; Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Singer+S%22">Singer S</searchLink>; Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schäfer-Ruoff+F%22">Schäfer-Ruoff F</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.<br /><searchLink fieldCode="AU" term="%22Malek+NP%22">Malek NP</searchLink>; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; Center for Personalized Medicine, Eberhard-Karls University, Tübingen, Germany.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schenke-Layland+K%22">Schenke-Layland K</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bitzer+M%22">Bitzer M</searchLink>; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany. m.bitzer@med.uni-tuebingen.de.; Center for Personalized Medicine, Eberhard-Karls University, Tübingen, Germany. m.bitzer@med.uni-tuebingen.de.; M3-Research Center for Malignome, Metabolome and Microbiome, Eberhard-Karls University, Tübingen, Germany. m.bitzer@med.uni-tuebingen.de.<br /><searchLink fieldCode="AU" term="%22Templin+MF%22">Templin MF</searchLink>; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. markus.templin@nmi.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2026 Feb 25; Vol. 10 (1). <i>Date of Electronic Publication: </i>2026 Feb 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41741733
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-026-01304-5
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stahl A
      – PersonEntity:
          Name:
            NameFull: Büringer K
      – PersonEntity:
          Name:
            NameFull: Missios P
      – PersonEntity:
          Name:
            NameFull: Hoffmann T
      – PersonEntity:
          Name:
            NameFull: Mattern S
      – PersonEntity:
          Name:
            NameFull: Singer S
      – PersonEntity:
          Name:
            NameFull: Schäfer-Ruoff F
      – PersonEntity:
          Name:
            NameFull: Malek NP
      – PersonEntity:
          Name:
            NameFull: Schenke-Layland K
      – PersonEntity:
          Name:
            NameFull: Bitzer M
      – PersonEntity:
          Name:
            NameFull: Templin MF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 02
              Text: 2026 Feb 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1